BPMC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.21%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $23,959,724.92

Blueprint Medicines Insider Trading History Chart

Blueprint Medicines Share Price & Price History

^$99.40

▼ -0.91 (-0.91%)

As of 05/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Blueprint Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/5/2025	Ariel Hurley	Insider	Sell	2,752	$103.13	$283,813.76	16,944
5/5/2025	Christina Rossi	COO	Sell	2,274	$101.75	$231,379.50	66,992
3/24/2025	Christina Rossi	COO	Sell	2,274	$95.02	$216,075.48	69,266
3/3/2025	Ariel Hurley	Insider	Sell	3,203	$92.62	$296,661.86	18,270
1/21/2025	Christina Rossi	COO	Sell	2,274	$110.14	$250,458.36	67,109
1/21/2025	Jeffrey W. Albers	Director	Sell	15,161	$109.53	$1,660,584.33	152,396
1/21/2025	Kate Haviland	CEO	Sell	1,446	$110.24	$159,407.04	149,378
1/13/2025	Ariel Hurley	Insider	Sell	2,250	$100.00	$225,000.00	14,967
1/13/2025	Jeffrey W. Albers	Director	Sell	5,000	$102.28	$511,400.00	157,557
12/19/2024	Jeffrey W. Albers	Director	Sell	15,000	$89.77	$1,346,550.00	157,557
12/18/2024	Christina Rossi	COO	Sell	2,274	$95.91	$218,099.34	69,383
12/12/2024	Ariel Hurley	Insider	Sell	1,819	$93.26	$169,639.94	14,967
11/29/2024	Kate Haviland	CEO	Sell	2,353	$96.60	$227,299.80	150,824
11/27/2024	Christina Rossi	COO	Sell	2,274	$95.10	$216,257.40	71,657
10/3/2024	Fouad Namouni	Insider	Sell	3,633	$89.32	$324,499.56	69,070
8/5/2024	Philina Lee	Insider	Sell	41,913	$93.19	$3,905,872.47	34,729
7/5/2024	Debra Durso-Bumpus	Insider	Sell	3,850	$111.20	$428,120.00	43,763
7/3/2024	Debra Durso-Bumpus	Insider	Sell	8,817	$111.29	$981,243.93	43,763
6/28/2024	Debra Durso-Bumpus	Insider	Sell	333	$111.15	$37,012.95	43,763
6/21/2024	Debra Durso-Bumpus	Insider	Sell	74,034	$104.19	$7,713,602.46	43,763
6/5/2024	Percy H. Carter	Insider	Sell	4,000	$105.13	$420,520.00	41,895
6/3/2024	L. Becker Hewes	Insider	Sell	4,922	$106.43	$523,848.46	31,938
5/31/2024	L. Becker Hewes	Insider	Sell	34,108	$105.91	$3,612,378.28	36,860
5/2/2024	Ariel Hurley	Insider	Sell	1,834	$103.88	$190,515.92	14,913
5/2/2024	Michael Landsittel	CFO	Sell	10,000	$105.00	$1,050,000.00	47,286
3/28/2024	Michael Landsittel	CFO	Sell	5,000	$95.00	$475,000.00	47,286
3/20/2024	Jeffrey W. Albers	Director	Sell	25,073	$87.28	$2,188,371.44	176,050
3/15/2024	Michael Landsittel	CFO	Sell	13,734	$87.78	$1,205,570.52	47,286
3/7/2024	Christina Rossi	COO	Sell	6,070	$90.69	$550,488.30	64,306
3/7/2024	Jeffrey W. Albers	Director	Sell	11,033	$90.69	$1,000,582.77	165,017
3/7/2024	Kate Haviland	CEO	Sell	12,464	$90.69	$1,130,360.16	153,177
3/7/2024	L. Becker Hewes	Insider	Sell	3,097	$90.69	$280,866.93	46,281
3/7/2024	Michael Landsittel	CFO	Sell	5,003	$90.69	$453,722.07	56,020
3/7/2024	Tracey L. Mccain	EVP	Sell	5,194	$90.69	$471,043.86	60,498
3/4/2024	Christopher K. Murray	Insider	Sell	621	$93.65	$58,156.65	36,374
2/28/2024	Christopher K. Murray	Insider	Sell	5,000	$100.00	$500,000.00	24,495
1/25/2024	Jeffrey W. Albers	Director	Sell	25,000	$81.91	$2,047,750.00	176,050
12/22/2023	Ariel Hurley	Insider	Sell	714	$90.00	$64,260.00	14,324
12/7/2023	Christopher K. Murray	Insider	Sell	5,000	$75.00	$375,000.00	24,495
12/4/2023	Christopher K. Murray	Insider	Sell	600	$71.43	$42,858.00	24,495
11/30/2023	Jeffrey W. Albers	Director	Sell	5,000	$70.55	$352,750.00	176,050
11/24/2023	Jeffrey W. Albers	Director	Sell	15,000	$67.51	$1,012,650.00	176,050
11/3/2023	Jeffrey W. Albers	Director	Sell	1,485	$60.13	$89,293.05	176,050
11/1/2023	Jeffrey W. Albers	Director	Sell	3,881	$60.02	$232,937.62	176,050
10/26/2023	Christopher K. Murray	Insider	Sell	600	$56.40	$33,840.00	25,095
10/4/2023	Fouad Namouni	Insider	Sell	3,769	$48.06	$181,138.14	62,080
9/28/2023	Jeffrey W. Albers	Director	Sell	6,898	$50.17	$346,072.66	176,050
8/25/2023	Jeffrey W. Albers	Director	Sell	10,000	$50.16	$501,600.00	176,050
6/5/2023	Percy H. Carter	Insider	Sell	2,307	$52.06	$120,102.42	38,117
3/6/2023	Christina Rossi	COO	Sell	3,059	$45.67	$139,704.53	55,376
3/6/2023	Christopher K. Murray	Insider	Sell	1,875	$45.68	$85,650.00	25,695
3/6/2023	Jeffrey W. Albers	Director	Sell	9,793	$45.67	$447,246.31	173,450
3/6/2023	Kate Haviland	CEO	Sell	6,640	$45.69	$303,381.60	125,641
3/6/2023	Michael Landsittel	CFO	Sell	3,007	$45.68	$137,359.76	48,523
3/6/2023	Tracey L. Mccain	EVP	Sell	3,322	$45.68	$151,748.96	52,666
12/5/2022	Jeffrey W. Albers	Director	Sell	20,000	$50.09	$1,001,800.00	183,243
11/3/2022	Christina Rossi	COO	Sell	533	$45.24	$24,112.92	43,435
11/3/2022	Kate Haviland	CEO	Buy	1,100	$43.98	$48,378.00	92,281
10/4/2022	Fouad Namouni	Insider	Sell	3,477	$67.30	$234,002.10	52,797
8/24/2022	Debra Durso-Bumpus	Insider	Sell	5,000	$75.11	$375,550.00	40,836
8/22/2022	Jeffrey W. Albers	Director	Sell	8,410	$70.54	$593,241.40	183,243
8/19/2022	Jeffrey W. Albers	Director	Sell	1,590	$70.02	$111,331.80	183,243
8/16/2022	Jeffrey W. Albers	Director	Sell	20,000	$68.41	$1,368,200.00	183,243
8/8/2022	Jeffrey W. Albers	Director	Sell	10,000	$70.07	$700,700.00	183,243
8/4/2022	Christopher K. Murray	SVP	Sell	2,500	$60.44	$151,100.00	21,320
6/6/2022	Percy H. Carter	Insider	Sell	1,908	$59.76	$114,022.08	28,685
3/17/2022	George Demetri	Director	Sell	10	$58.56	$585.60	5,812

See Full Table

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

Blueprint Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/13/2025	Northern Trust Corp	589,559	$52.18M	0.0%	-3.1%	0.913%
5/13/2025	Algert Global LLC	68,420	$6.06M	0.1%	-39.0%	0.106%
5/13/2025	Raymond James Financial Inc.	193,812	$17.15M	0.0%	-19.9%	0.300%
5/13/2025	American Century Companies Inc.	866,763	$76.72M	0.0%	+3.3%	1.342%
5/13/2025	Fox Run Management L.L.C.	11,445	$1.01M	0.2%	+11.5%	0.018%
5/13/2025	Sei Investments Co.	70,693	$6.17M	0.1%	+0.4%	0.109%
5/13/2025	Oak Ridge Investments LLC	14,547	$1.29M	0.1%	+2.5%	0.023%
5/13/2025	Lord Abbett & CO. LLC	288,472	$25.53M	0.1%	-13.9%	0.447%
5/13/2025	E Fund Management Co. Ltd.	9,282	$0.82M	0.0%	+46.9%	0.014%
5/13/2025	Russell Investments Group Ltd.	169,115	$14.97M	0.0%	+34.3%	0.262%
5/12/2025	Nuveen LLC	267,660	$23.39M	0.0%	N/A	0.414%
5/12/2025	Aigen Investment Management LP	3,706	$0.33M	0.1%	-17.4%	0.006%
5/12/2025	Invesco Ltd.	984,674	$87.15M	0.0%	+2.5%	1.525%
5/12/2025	Covestor Ltd	1,128	$100K	0.1%	+15.9%	0.002%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	183,947	$16.28M	0.1%	+28.9%	0.285%
5/12/2025	NBW Capital LLC	34,678	$3.07M	0.7%	-21.0%	0.054%
5/12/2025	Swiss National Bank	123,100	$10.90M	0.0%	-1.2%	0.191%
5/9/2025	Headlands Technologies LLC	936	$83K	0.0%	+25.0%	0.001%
5/9/2025	Deutsche Bank AG	199,937	$17.70M	0.0%	-23.5%	0.310%
5/9/2025	Charles Schwab Investment Management Inc.	599,721	$53.08M	0.0%	-0.8%	0.929%
5/9/2025	Vanguard Group Inc.	6,640,523	$587.75M	0.0%	-2.0%	10.282%
5/9/2025	Intrust Bank NA	3,557	$0.32M	0.0%	+3.4%	0.006%
5/9/2025	BIT Capital GmbH	77,802	$6.89M	0.6%	-1.4%	0.120%
5/8/2025	Blueshift Asset Management LLC	3,086	$0.27M	0.1%	N/A	0.005%
5/8/2025	Jefferies Financial Group Inc.	45,200	$4M	0.0%	-4.8%	0.070%
5/8/2025	US Bancorp DE	8,326	$0.74M	0.0%	-16.6%	0.013%
5/8/2025	Torray Investment Partners LLC	16,679	$1.48M	0.2%	+1.1%	0.026%
5/8/2025	XTX Topco Ltd	7,311	$0.65M	0.0%	-34.4%	0.011%
5/8/2025	S&CO Inc.	13,795	$1.22M	0.1%	+38.0%	0.021%
5/7/2025	Essex Investment Management Co. LLC	41,525	$3.68M	0.8%	-9.2%	0.065%
5/7/2025	Mackenzie Financial Corp	16,196	$1.43M	0.0%	+14.2%	0.025%
5/7/2025	LPL Financial LLC	16,205	$1.43M	0.0%	+103.7%	0.025%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	17,004	$1.51M	0.0%	+6.7%	0.027%
5/7/2025	TD Asset Management Inc	284,372	$25.17M	0.0%	-6.3%	0.445%
5/7/2025	Knights of Columbus Asset Advisors LLC	12,995	$1.15M	0.1%	+2.7%	0.020%
5/6/2025	Neo Ivy Capital Management	5,754	$0.51M	0.2%	N/A	0.009%
5/6/2025	Royce & Associates LP	18,001	$1.59M	0.0%	N/A	0.028%
5/6/2025	KLP Kapitalforvaltning AS	12,300	$1.09M	0.0%	-4.7%	0.019%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	84,780	$7.50M	0.0%	N/A	0.133%
5/6/2025	Y Intercept Hong Kong Ltd	21,522	$1.91M	0.1%	N/A	0.034%
5/5/2025	Crestwood Advisors Group LLC	7,630	$0.68M	0.0%	N/A	0.012%
5/5/2025	Allianz Asset Management GmbH	9,100	$0.81M	0.0%	-34.1%	0.014%
5/5/2025	Teachers Retirement System of The State of Kentucky	10,743	$0.95M	0.0%	-35.0%	0.017%
5/5/2025	Jennison Associates LLC	348,817	$30.87M	0.0%	-3.2%	0.546%
5/2/2025	Segall Bryant & Hamill LLC	135,909	$12.03M	0.2%	-2.7%	0.213%
5/2/2025	Victory Capital Management Inc.	15,305	$1.36M	0.0%	-4.5%	0.024%
5/2/2025	Massachusetts Financial Services Co. MA	270,996	$23.99M	0.0%	+0.4%	0.424%
5/1/2025	CWM LLC	5,321	$0.47M	0.0%	+62.3%	0.008%
5/1/2025	Stephens Inc. AR	5,084	$0.45M	0.0%	+38.0%	0.008%
5/1/2025	Emerald Advisers LLC	401,644	$35.55M	1.6%	-3.7%	0.628%
5/1/2025	New York State Common Retirement Fund	19,820	$1.75M	0.0%	+1.5%	0.031%
5/1/2025	Mutual of America Capital Management LLC	34,521	$3.06M	0.0%	+7.5%	0.053%
5/1/2025	Arizona State Retirement System	18,202	$1.61M	0.0%	-0.8%	0.028%
5/1/2025	Emerald Mutual Fund Advisers Trust	250,158	$22.14M	1.6%	-7.0%	0.391%
5/1/2025	Xponance Inc.	5,021	$0.44M	0.0%	+5.0%	0.008%
4/30/2025	Cerity Partners LLC	4,628	$0.41M	0.0%	+40.3%	0.007%
4/30/2025	Brown Advisory Inc.	581,864	$51.50M	0.1%	+0.5%	0.910%
4/30/2025	China Universal Asset Management Co. Ltd.	12,818	$1.14M	0.1%	-4.8%	0.020%
4/29/2025	Envestnet Asset Management Inc.	39,893	$3.53M	0.0%	+24.2%	0.062%
4/29/2025	Bank of New York Mellon Corp	307,018	$27.17M	0.0%	+1.2%	0.480%
4/29/2025	GF Fund Management CO. LTD.	1,626	$0.14M	0.0%	+21.9%	0.003%
4/29/2025	Calamos Advisors LLC	3,721	$0.33M	0.0%	N/A	0.006%
4/29/2025	Moody Aldrich Partners LLC	22,331	$1.98M	0.4%	N/A	0.035%
4/28/2025	Teacher Retirement System of Texas	17,097	$1.51M	0.0%	-8.9%	0.027%
4/25/2025	Peregrine Capital Management LLC	96,149	$8.51M	0.3%	-2.7%	0.150%
4/24/2025	Allspring Global Investments Holdings LLC	4,957	$0.43M	0.0%	+53.8%	0.008%
4/24/2025	Diversified Trust Co	15,226	$1.35M	0.0%	+105.3%	0.024%
4/23/2025	AMI Asset Management Corp	10,964	$0.97M	0.1%	N/A	0.017%
4/17/2025	Exchange Traded Concepts LLC	1,383	$0.12M	0.0%	-31.2%	0.002%
4/16/2025	Wealth Enhancement Advisory Services LLC	3,353	$0.30M	0.0%	N/A	0.005%
4/15/2025	Fifth Third Bancorp	3,221	$0.29M	0.0%	+4.7%	0.005%
4/15/2025	Assenagon Asset Management S.A.	76,270	$6.75M	0.0%	-21.7%	0.119%
4/15/2025	SG Americas Securities LLC	7,276	$0.64M	0.0%	+70.1%	0.011%
4/14/2025	Pallas Capital Advisors LLC	6,843	$0.61M	0.0%	+19.4%	0.011%
4/9/2025	NBC Securities Inc.	2,648	$0.23M	0.0%	+132,300.0%	0.004%
4/8/2025	Rhumbline Advisers	91,933	$8.14M	0.0%	+6.2%	0.144%
4/7/2025	GAMMA Investing LLC	28,854	$2.55M	0.0%	+11,972.8%	0.045%
3/18/2025	California State Teachers Retirement System	59,259	$5.17M	0.0%	+4.9%	0.093%
2/27/2025	Jefferies Financial Group Inc.	47,500	$4.14M	0.0%	-12.2%	0.074%
2/20/2025	Mackenzie Financial Corp	14,177	$1.24M	0.0%	+99.6%	0.022%
2/19/2025	GF Fund Management CO. LTD.	1,334	$0.12M	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	239,946	$20.93M	0.0%	+5.3%	0.378%
2/17/2025	Voloridge Investment Management LLC	213,697	$18.64M	0.1%	-25.7%	0.336%
2/17/2025	Woodline Partners LP	540,192	$47.12M	0.3%	+19.1%	0.850%
2/17/2025	Zimmer Partners LP	33,650	$2.94M	0.1%	+59.5%	0.053%
2/17/2025	Tema Etfs LLC	22,474	$1.96M	0.8%	N/A	0.035%
2/17/2025	Sherbrooke Park Advisers LLC	3,374	$0.29M	0.1%	+8.4%	0.005%
2/17/2025	Rafferty Asset Management LLC	88,891	$7.75M	0.0%	-24.0%	0.140%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	1,220	$0.11M	0.0%	N/A	0.002%
2/17/2025	Point72 Asset Management L.P.	166,418	$14.52M	0.0%	N/A	0.262%
2/17/2025	Point72 Europe London LLP	43,568	$3.80M	0.2%	N/A	0.069%
2/17/2025	Point72 Hong Kong Ltd	2,218	$0.19M	0.0%	N/A	0.003%
2/17/2025	Polar Capital Holdings Plc	626,379	$54.63M	0.3%	-28.6%	0.986%
2/17/2025	ProShare Advisors LLC	20,915	$1.82M	0.0%	+33.9%	0.033%
2/17/2025	Prosight Management LP	67,000	$5.84M	1.6%	+42.3%	0.105%
2/17/2025	Man Group plc	103,919	$9.06M	0.0%	-80.0%	0.164%
2/17/2025	Nuveen Asset Management LLC	419,190	$36.56M	0.0%	+49.2%	0.660%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	20,133	$1.76M	0.1%	-9.5%	0.032%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	42,855	$3.74M	0.0%	+1.4%	0.067%
2/17/2025	Lazard Asset Management LLC	1,378	$0.12M	0.0%	-86.4%	0.002%

Data available starting January 2016

See Full Table

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $99.40

$98.50

$100.52

50 Day Range

MA: $88.91

$79.22

$104.64

52 Week Range

Now: $99.40

$73.04

$121.90

Volume

595,632 shs

Average Volume

778,224 shs

Market Capitalization

$6.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of Blueprint Medicines?: Blueprint Medicines' top insider investors include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Christopher K Murray (Insider)
Philina Lee (Insider)
Ariel Hurley (Insider)
Learn More about top insider investors at Blueprint Medicines.
Who are the major institutional investors of Blueprint Medicines?: Blueprint Medicines' top institutional investors include:
Vanguard Group Inc. — 10.28%
Invesco Ltd. — 1.52%
American Century Companies Inc. — 1.34%
Charles Schwab Investment Management Inc. — 0.93%
Brown Advisory Inc. — 0.91%
Emerald Advisers LLC — 0.63%
Learn More about top institutional investors of Blueprint Medicines stock.
Which major investors are selling Blueprint Medicines stock?: In the previous quarter, BPMC stock was sold by these institutional investors:
Vanguard Group Inc.
Deutsche Bank AG
Lord Abbett & CO. LLC
Assenagon Asset Management S.A.
TD Asset Management Inc
Emerald Mutual Fund Advisers Trust
Emerald Advisers LLC
Jennison Associates LLC
Within the last year, company insiders that have sold Blueprint Medicines company stock include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Learn More investors selling Blueprint Medicines stock.
Which major investors are buying Blueprint Medicines stock?: During the last quarter, BPMC stock was bought by institutional investors including:
Nuveen LLC
Universal Beteiligungs und Servicegesellschaft mbH
Russell Investments Group Ltd.
Connor Clark & Lunn Investment Management Ltd.
GAMMA Investing LLC
American Century Companies Inc.
Invesco Ltd.
Citigroup Inc.